What are Thermo Fisher Scientific's primary revenue drivers?

Thermo Fisher Scientific generates revenue from a wide array of products and services, including analytical instruments, laboratory equipment, reagents, consumables, software, and services for scientific research, diagnostics, and industrial applications. Key segments often include Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

How is Thermo Fisher Scientific managing its growth and market position?

The company employs a multi-pronged strategy for growth, encompassing organic growth through innovation and new product development, as well as inorganic growth through strategic acquisitions. It focuses on integrating acquired businesses effectively to realize synergies and expand its market reach.

What are the key trends impacting Thermo Fisher Scientific's business?

Key trends include the increasing demand for biopharmaceuticals and biologics manufacturing, advancements in genetic sequencing and gene editing, the growth of personalized medicine, and the need for advanced diagnostic tools. The company's investments are often aligned with these significant market shifts.

What is the significance of the company's filings with the SEC?

SEC filings, such as the 10-K annual report, provide crucial audited financial information, management discussions, risk factors, and disclosures about the company's operations, strategy, and governance. They are essential for investors to make informed decisions about the company's performance and prospects.

TMO 10-K FY2012 Annual Report — Revenue, Net Income, EPS

Summary

Thermo Fisher Scientific Inc. (TMO) filed its 2012 10-K on February 27, 2013, detailing its financial performance and strategic positioning. The company continued to demonstrate strong execution, driven by its diverse portfolio of products and services that serve a broad range of customers in life sciences research, healthcare, industrial, and applied markets. Key to its success was the ongoing integration of its acquired businesses and a focus on innovation to maintain its competitive edge. Investors should note the company's commitment to expanding its global reach and investing in high-growth areas within the life sciences sector.

Financial Highlights

57 data points

Beta

Revenue

$12.51B

0.5% Gross Margin

Net Income

$1.18B

0.1% Net Margin

EPS (Diluted)

$3.21

Total Assets

$27.44B

Cash & Equivalents

$805.60M

Free Cash Flow

$1.72B

Financial Statements

Beta

Revenue	$12.51B
Cost of Revenue	$6.10B
Gross Profit	$6.41B
R&D Expenses	$376.40M
SG&A Expenses	$3.35B
Operating Expenses	$11.03B
Operating Income	$1.48B
Interest Expense	$241.60M
Net Income	$1.18B
EPS (Basic)	$3.24
EPS (Diluted)	$3.21
Shares Outstanding (Basic)	363.80M
Shares Outstanding (Diluted)	366.60M

Key Highlights

1Thermo Fisher Scientific operates in a dynamic and growing life sciences and diagnostics market.
2The company's diversified business model across various end markets (life sciences research, healthcare, industrial, applied) provides resilience.
3Strategic acquisitions and integrations are a key part of the company's growth strategy.
4Focus on innovation and product development to drive organic growth.
5Commitment to expanding global presence and serving a broad customer base.
6The company is well-positioned to benefit from trends in personalized medicine and biopharmaceutical manufacturing.

THERMO FISHER SCIENTIFIC INC. Annual Report (Amendment), Year Ended Dec 31, 2012

Summary

Financial Highlights

Key Highlights

Frequently Asked Questions